Klotho deficiency, prevalent in CKD and aging, increases vascular susceptibility to phosphate toxicity and promotes osteogenic reprogramming of VSMCs through BMP-SMAD-RUNX2 signaling, endothelial dysfunction and arterial stiffening [64,65,66,67,68]. This evidence concerns the gene KL and endothelial dysfunction.